节点文献

A33抗原表达调控机制及其抗体导向肿瘤放射免疫治疗

Mechanism of A33’ Tissue-Specific Expression and A33-Induced Radioimmunotherapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张勇王振宁

【Author】 ZHANG Yong~(1,2),WANG Zhenning~(2)~(1)Department of Surgical Oncology,the First Hospital of China Medical University,Shenyang,110001,China~(2)The Research Center for Medical Genomics,China Medical University,Shenyang,110001,China

【机构】 中国医科大学附属第一医院肿瘤外科中国医科大学医学基因组教研室 沈阳市110001中国医科大学医学基因组教研室沈阳市110001沈阳市110001

【摘要】 人肠上皮细胞表面抗原A33是一种在人胃肠道上皮细胞特异性表达的跨膜糖蛋白,在95%以上的大肠癌、63%的胃癌和50%的胰腺癌中表达,而在其它组织或其它肿瘤细胞中鲜有表达。近年来就A33的组织特异性表达模式进行了深入的研究,揭示了与A33的特异性表达相关的特异性启动子和组织特异性转录因子(GKLF、CDX1)。A33抗体导向下的直肠癌放射免疫治疗已成为单克隆抗体(monoc lonal an-tibody,MCAB)导向治疗研究领域的热点,且已经进入Ⅰ期放射免疫治疗临床实验。

【Abstract】 The human intestine tissue specific antigen A33 is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily.It is expressed in more than 95% of human colon cancers,63% of gastric cancers and 50% of pancreatic cancers,and it has not been found to express in other tissues or cancers.Over the past years,a lot of work has been done on the tissue-specific expression profile,and scientists have identified the promotor and transcription factor(GKLF、CDX1) that are associated with specific expression of A33.Advances have been made in the research of monolclonal antibodies for radioimmunotherapy and now the study is in the phase I trial in patients with advanced colorectal carcinoma.

【基金】 国家自然科学基金(No.30300342)~~
  • 【文献出处】 医学分子生物学杂志 ,Journal of Medical Molecular Biology , 编辑部邮箱 ,2006年03期
  • 【分类号】R730.5
  • 【被引频次】1
  • 【下载频次】88
节点文献中: 

本文链接的文献网络图示:

本文的引文网络